Works matching AU Akkerman, Onno W.


Results: 33
    1
    2
    3
    4
    5
    6
    7

    Reply to Verhaeghe et al.

    Published in:
    2016
    By:
    • Akkerman, Onno W.;
    • van Hateren, Kai;
    • Koster, Remco A.;
    • Luijckx, Gert-Jan R.;
    • van der Werf, Tjip S.;
    • Alffenaar, Jan-Willem C.
    Publication type:
    Letter to the Editor
    8

    Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.

    Published in:
    2016
    By:
    • Tiberi, Simon;
    • Sotgiu, Giovanni;
    • D'Ambrosio, Lia;
    • Centis, Rosella;
    • Arbex, Marcos Abdo;
    • Arrascue, Edith Alarcon;
    • Alffenaar, Jan Willem;
    • Caminero, Jose A.;
    • Gaga, Mina;
    • Gualano, Gina;
    • Skrahina, Alena;
    • Solovic, Ivan;
    • Sulis, Giorgia;
    • Tadolini, Marina;
    • Guizado, Valentina Alarcon;
    • De Lorenzo, Saverio;
    • Arias, Aurora Jazmín Roby;
    • Scardigli, Anna;
    • Akkerman, Onno W.;
    • Aleksa, Alena
    Publication type:
    Letter to the Editor
    9
    10

    The Never Ending Struggle Against Development of Drug Resistance.

    Published in:
    Clinical Infectious Diseases, 2015, v. 61, n. 1, p. 137, doi. 10.1093/cid/civ238
    By:
    • Daskapan, Alper;
    • Stienstra, Ymkje;
    • Akkerman, Onno W.;
    • de Lange, Wiel C. M.;
    • Kosterink, Jos G. W.;
    • van der Werf, Tjip S.;
    • Alffenaar, Jan-Willem C.;
    • Narendran, Gopalan;
    • Swaminathan, Soumya
    Publication type:
    Article
    11
    12

    Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-38889-x
    By:
    • Niewold, Paula;
    • Dijkstra, Douwe J.;
    • Cai, Yi;
    • Goletti, Delia;
    • Palmieri, Fabrizio;
    • van Meijgaarden, Krista E.;
    • Verreck, Frank A. W.;
    • Akkerman, Onno W.;
    • Hofland, Regina W.;
    • Delemarre, Eveline M.;
    • Nierkens, Stefan;
    • Verheul, Marije K.;
    • Pollard, Andrew J.;
    • van Dissel, Jaap T.;
    • Ottenhoff, Tom H. M.;
    • Trouw, Leendert A.;
    • Joosten, Simone A.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    The pharmacokinetics of antibiotics in cystic fibrosis.

    Published in:
    Expert Opinion on Drug Metabolism & Toxicology, 2021, v. 17, n. 1, p. 53, doi. 10.1080/17425255.2021.1836157
    By:
    • Akkerman-Nijland, Anne M.;
    • Akkerman, Onno W.;
    • Grasmeijer, Floris;
    • Hagedoorn, Paul;
    • Frijlink, Henderik. W.;
    • Rottier, Bart. L.;
    • Koppelman, Gerard. H.;
    • Touw, Daniel. J.
    Publication type:
    Article
    25
    26
    27
    28

    Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.

    Published in:
    Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.725447
    By:
    • Delemarre, Eveline M.;
    • van Hoorn, Laura;
    • Bossink, Aik W. J.;
    • Drylewicz, Julia;
    • Joosten, Simone A.;
    • Ottenhoff, Tom H. M.;
    • Akkerman, Onno W.;
    • Goletti, Delia;
    • Petruccioli, Elisa;
    • Navarra, Assunta;
    • van den Broek, Brigitte T. A.;
    • Paardekooper, Sanne P. A.;
    • van Haeften, Ineke;
    • Koenderman, Leo;
    • Lammers, Jan-Willem J.;
    • Thijsen, Steven F. T.;
    • Hofland, Regina W.;
    • Nierkens, Stefan
    Publication type:
    Article
    29
    30
    31
    32
    33